Extended donor criteria in lung transplantation: Impact on organ allocation

被引:96
作者
Botha, P [1 ]
Trivedi, D
Weir, CJ
Searl, CP
Corris, PA
Dark, JH
Schueler, SVB
机构
[1] Freeman Rd Hosp, Dept Cardiopulm Transplantat, Newcastle Upon Tyne NE7 7DN, Tyne & Wear, England
[2] Univ Glasgow, Robertson Ctr Biostat, Glasgow, Lanark, Scotland
[3] Newcastle Univ, Immunol & Transplantat Res Grp, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England
关键词
D O I
10.1016/j.jtcvs.2005.12.037
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Some reports have documented a higher early mortality with the use of extended criteria donors in lung transplantation. None have evaluated how outcomes compare with the use of these organs for single and bilateral transplantation or whether this practice results in a higher incidence of early bronchiolitis obliterans syndrome. Methods: We performed a retrospective review of case notes, intensive therapy unit database, and donor details. Between January 1, 2000, and December 31, 2004, 201 patients underwent lung or heart-lung transplantation. Results: Eighty-three (41.3%) patients received organs deemed marginal on the basis of at least one of the following criteria: donor age greater than 55 years, duration of ventilation greater than 5 days, purulent secretions or inflammation at bronchoscopy, smoking of 20 or more cigarettes per day, abnormality on chest roentgenogram, or PO2/fraction of inspired oxygen ratio of less than 300 mm Hg immediately before donor organ procurement. Recipients of marginal lungs had a higher incidence of severe ( grade 3) primary graft dysfunction (43.9% vs 27.4%, P=.015) and 90-day organ-specific mortality (15.7% vs 5.1%, P=.012). Bilateral transplantation carried a significantly higher 30-day mortality if performed with marginal organs (17.0% vs 2.7% with standard donor organs, P=.005). Thirty-day mortality was not significantly different for the transplantation of single marginal or standard donor lungs. Cumulative survival and survival free of bronchiolitis obliterans syndrome was not affected by marginal donor status. Conclusion: Transplantation of extended criteria donor lungs leads to a higher incidence of primary graft dysfunction. Bilateral transplantation with these organs seems to confer less reserve, resulting in a higher early mortality rate. Medium-term functional outcome is, however, not adversely affected by the relaxation of donor criteria.
引用
收藏
页码:1154 / 1160
页数:7
相关论文
共 19 条
[1]   Liberalization of donor criteria may expand the donor pool without adverse consequence in lung transplantation [J].
Bhorade, SM ;
Vigneswaran, W ;
McCabe, MA ;
Garrity, ER .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2000, 19 (12) :1199-1204
[2]   Assessment of survival benefit after lung transplantation by patient diagnosis [J].
Charman, SC ;
Sharples, LD ;
McNeil, KD ;
Wallwork, J .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2002, 21 (02) :226-232
[3]   Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part II: Definition. A consensus statement of the International Society for Heart and Lung Transplantation [J].
Christie, JD ;
Carby, M ;
Bag, R ;
Corris, P ;
Hertz, M ;
Weill, D .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2005, 24 (10) :1454-1459
[4]   Listing for lung transplantation: Life expectancy and transplant effect, stratified by type of end-stage lung disease, the eurotransplant experience [J].
De Meester, J ;
Smits, JMA ;
Persijn, GG ;
Haverich, A .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2001, 20 (05) :518-524
[5]   Bronchiolitis obliterans syndrome 2001: An update of the diagnostic criteria [J].
Estenne, M ;
Maurer, JR ;
Boehler, A ;
Egan, JJ ;
Frost, A ;
Hertz, M ;
Mallory, GB ;
Snell, GI ;
Yousem, S .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2002, 21 (03) :297-310
[6]   Non-immune acute graft injury after lung transplantation and the risk of subsequent bronchiolitis obliterans syndrome (BOS) [J].
Fisher, AJ ;
Wardle, J ;
Dark, JH ;
Corris, PA .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2002, 21 (11) :1206-1212
[7]   Maximizing the utilization of donor organs offered for lung transplantation [J].
Gabbay, E ;
Williams, TJ ;
Griffiths, AP ;
Macfarlane, LM ;
Kotsimbos, TC ;
Esmore, DS ;
Snell, GI .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 160 (01) :265-271
[8]   Effect of diagnosis on survival benefit of lung transplantation for end-stage lung disease [J].
Hosenpud, JD ;
Bennett, LE ;
Keck, BM ;
Edwards, EB ;
Novick, RJ .
LANCET, 1998, 351 (9095) :24-27
[9]   SUCCESSFUL TRANSPLANTATION OF MARGINALLY ACCEPTABLE THORACIC ORGANS [J].
KRON, IL ;
TRIBBLE, CG ;
KERN, JA ;
DANIEL, TM ;
ROSE, CE ;
TRUWIT, JD ;
BLACKBOURNE, LH ;
BERGIN, JD .
ANNALS OF SURGERY, 1993, 217 (05) :518-524
[10]   Extended donor lungs: eleven years experience in a consecutive series [J].
Lardinois, D ;
Banysch, M ;
Korom, S ;
Hillinger, S ;
Rousson, V ;
Boehler, A ;
Speich, R ;
Weder, W .
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2005, 27 (05) :762-767